Treatment Algorithm

Question 1

which classes (and drugs) are recommended in patients with Type 2 diabetes with ASCVD (or high risk) and as an ALTERNATIVE in CKD*

Answer 1

1. GLP- 1 agonists (Liraglutide= Victoza, Dulaglutide= Trulicity, SC Semaglutide= Ozempic)**
2. SGLT2 inhibitors (Canagliflozin= Invokana, dapagliflozin= Farxiga, Empagliflozin= Jardiance, Ertugliflozin= Steglatro)

Question 2

Q: GLP-1 and GIP agonists are ALL administered how
Q: what is the exception

Answer 2

1. ALL or SUBCUTANEOUS (SC) injections
2. exception is semaglutide which also comes in PO formulation known as Rybelsus

Question 3

GLP-1a/ GIP agonists names end in

Answer 3

-tide

Question 4

List GLP-1 agonists

Answer 4

*Liraglutide (Victoza) - Saxenda for wt loss

*Semaglutide (SC: Ozempic an PO: Rybelsus) - Wegovy for wt loss

*Dulaglutide (Trulicity)

Exenatide (Byetta)

Exenatide ER (Bydureon BCise)

Question 5

List DUAL GLP-1/GIP agonists AKA “Twincretin”

Answer 5

Tirzepatide (Mounjaro) - ZEPBOUND for wt loss*